Cogent Biosciences (COGT) Operating Income: 2017-2020
Historic Operating Income for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$82.2 million.
- Cogent Biosciences' Operating Income fell 611.43% to -$11.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.2 million, marking a year-over-year decrease of 155.45%. This contributed to the annual value of -$82.2 million for FY2020, which is 155.45% down from last year.
- Cogent Biosciences' Operating Income amounted to -$82.2 million in FY2020, which was down 155.45% from -$32.2 million recorded in FY2019.
- In the past 5 years, Cogent Biosciences' Operating Income registered a high of -$26.2 million during FY2017, and its lowest value of -$82.2 million during FY2020.
- Its 3-year average for Operating Income is -$50.1 million, with a median of -$36.0 million in 2018.
- Per our database at Business Quant, Cogent Biosciences' Operating Income rose by 10.63% in 2019 and then plummeted by 155.45% in 2020.
- Cogent Biosciences' Operating Income (Yearly) stood at -$26.2 million in 2017, then tumbled by 37.68% to -$36.0 million in 2018, then increased by 10.63% to -$32.2 million in 2019, then plummeted by 155.45% to -$82.2 million in 2020.